MDMA’s Leahey Sees Reasons for Concern and Optimism
Mark Leahey of the MDMA explains how a move against patent troll could cut the legs out from Medtech entrepreneurs and VCs dependent upon IP protection.
MDMA’s Leahey Sees Reasons for Concern and Optimism
Mark Leahey of the MDMA explains how a move against patent troll could cut the legs out from Medtech entrepreneurs and VCs dependent upon IP protection.